BioCentury
ARTICLE | Clinical News

Cytolin: Phase Ia

December 3, 2001 8:00 AM UTC

AMUN said results of an open-label U.S. trial showed Cytolin was well tolerated in 13 patients at doses of 0.05 mg/kg and 0.10 mg/kg. No serious adverse events were reported. ...